Healthcare provider profile · identity verified

Sarah E Whitehead, MD

Family Practice · GREENVILLE, SC · NPI 1699041160

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	509	150
Atorvastatin Calcium	Atorvastatin Calcium	388	124
Omeprazole	Omeprazole	334	98
Amlodipine Besylate	Amlodipine Besylate	316	106
Lisinopril	Lisinopril	290	90
Rosuvastatin Calcium	Rosuvastatin Calcium	266	93
Metoprolol Succinate	Metoprolol Succinate	257	82
Sertraline Hcl	Sertraline Hcl	214	62
Losartan Potassium	Losartan Potassium	192	63
Metformin Hcl	Metformin Hcl	192	74
Hydrochlorothiazide	Hydrochlorothiazide	190	58
Albuterol Sulfate Hfa	Albuterol Sulfate	186	78
Gabapentin	Gabapentin	183	57
Furosemide	Furosemide	165	65
Montelukast Sodium	Montelukast Sodium	161	49
Fluticasone Propionate	Fluticasone Propionate	144	66
Pantoprazole Sodium	Pantoprazole Sodium	141	54
Trazodone Hcl	Trazodone Hcl	134	48
Eliquis	Apixaban	130	30
Meloxicam	Meloxicam	129	45
Simvastatin	Simvastatin	121	37
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	117	37
Famotidine	Famotidine	114	40
Lorazepam	Lorazepam	107	19
Carvedilol	Carvedilol	95	33
Duloxetine Hcl	Duloxetine Hcl	93	30
Tramadol Hcl	Tramadol Hcl	93	35
Pravastatin Sodium	Pravastatin Sodium	92	26
Alendronate Sodium	Alendronate Sodium	82	28
Metoprolol Tartrate	Metoprolol Tartrate	77	26
Ozempic	Semaglutide	75	14
Escitalopram Oxalate	Escitalopram Oxalate	73	28
Prednisone	Prednisone	70	51
Diclofenac Sodium	Diclofenac Sodium	69	27
Tizanidine Hcl	Tizanidine Hcl	68	23
Synthroid	Levothyroxine Sodium	66	21
Zolpidem Tartrate	Zolpidem Tartrate	65	14
Bupropion Xl	Bupropion Hcl	62	20
Atenolol	Atenolol	61	14
Celecoxib	Celecoxib	61	15
Allopurinol	Allopurinol	60	19
Estradiol	Estradiol	57	24
Ezetimibe	Ezetimibe	57	20
Nystatin	Nystatin	57	23
Fluoxetine Hcl	Fluoxetine Hcl	55	19
Ondansetron Odt	Ondansetron	55	28
Esomeprazole Magnesium	Esomeprazole Magnesium	52	17
Alprazolam	Alprazolam	50	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	16
Quetiapine Fumarate	Quetiapine Fumarate	49	11
Trulicity	Dulaglutide	49	suppressed
Clonazepam	Clonazepam	46	12
Buspirone Hcl	Buspirone Hcl	45	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	45	17
Wixela Inhub	Fluticasone Propion/Salmeterol	45	16
Metformin Hcl Er	Metformin Hcl	44	16
Spironolactone	Spironolactone	44	17
Fluconazole	Fluconazole	43	24
Tamsulosin Hcl	Tamsulosin Hcl	41	19
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	40	15
Potassium Chloride	Potassium Chloride	39	17
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	38	suppressed
Ibuprofen	Ibuprofen	38	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	12
Azithromycin	Azithromycin	37	34
Hydroxyzine Hcl	Hydroxyzine Hcl	37	14
Triamcinolone Acetonide	Triamcinolone Acetonide	37	24
Chlorthalidone	Chlorthalidone	36	12
Januvia	Sitagliptin Phosphate	36	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	36	suppressed
Valacyclovir	Valacyclovir Hcl	36	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	34
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	12
Citalopram Hbr	Citalopram Hydrobromide	34	12
Tresiba Flextouch U-100	Insulin Degludec	34	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	33	28
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Propranolol Hcl	Propranolol Hcl	33	suppressed
Glipizide	Glipizide	32	suppressed
Clopidogrel	Clopidogrel Bisulfate	31	13
Valsartan	Valsartan	31	suppressed
Benazepril Hcl	Benazepril Hcl	30	suppressed
Ondansetron Hcl	Ondansetron Hcl	30	12
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	27
Donepezil Hcl	Donepezil Hcl	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	15
Mounjaro	Tirzepatide	27	12
Naproxen	Naproxen	27	suppressed
Novolog Flexpen	Insulin Aspart	27	12
Pregabalin	Pregabalin	27	suppressed
Ramipril	Ramipril	27	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Temazepam	Temazepam	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Torsemide	Torsemide	21	suppressed
Tresiba Flextouch U-200	Insulin Degludec	21	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Baclofen	Baclofen	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Rivastigmine	Rivastigmine Tartrate	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Colchicine	Colchicine	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Epinephrine	Epinephrine	15	11
Gemfibrozil	Gemfibrozil	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	15	suppressed
Novolin N	Insulin Nph Human Isophane	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Cilostazol	Cilostazol	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Topiramate	Topiramate	14	suppressed
Finasteride	Finasteride	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Dilantin	Phenytoin Sodium Extended	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Toprol Xl	Metoprolol Succinate	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Progesterone	Progesterone, Micronized	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Risperidone	Risperidone	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error